Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M. Sea Pharmaceuticals is an India-based pharmaceutical company engaged in the manufacturing, supplying, and exporting of a diverse range of pharmaceutical formulations. The company's product portfolio includes tablets, capsules, liquid orals, and ointments across various therapeutic segments such as antibiotics, analgesics, and anti-infectives. M. Sea Pharmaceuticals caters to both the Indian domestic market and international markets, focusing on high-quality generic drug production. The firm operates manufacturing facilities that adhere to regulatory standards to ensure the efficacy and safety of its medicinal products. Their business model is primarily focused on the commercialization of established small molecule generics rather than proprietary drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M. Sea Pharmaceutical.